NDC 55289-920-98
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-920
- Requested NDC
- 55289-920-98
- Package NDCs from labels
- 55289-920-98
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-920-06 | EA - Each | 55289-920 | 706d0221-1af2-41d4-9df2-bf37b14b690f | 1 | 2012-07-24 |
| 55289-920-30 | EA - Each | 55289-920 | 29427292-7c0b-4173-859f-ff32c417f2e7 | 1 | 2012-07-24 |
| 55289-920-40 | EA - Each | 55289-920 | 27fb6d9e-1de6-4d20-a60e-6518e959ca62 | 1 | 2012-07-24 |
| 55289-920-60 | EA - Each | 55289-920 | d88ef8cb-70eb-456a-8133-6265354cbc4a | 1 | 2012-07-24 |
| 55289-920-90 | EA - Each | 55289-920 | cd4fb9c8-ca98-40b2-8d76-5faca8c9fb4e | 1 | 2012-07-24 |
| 55289-920-98 | EA - Each | 55289-920 | 2a336a9c-9f8d-4b3f-8c19-cc8e37318b9d | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | f34e4747-28be-4ae5-ac9a-a825083b6a9b | 2026-01-12 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Pindolol | PINDOLOL | PD-Rx Pharmaceuticals, Inc. | f91e5715-e37d-45fa-97a7-4d32fbd51060 | 2026-01-12 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 7e236f83-14bf-4862-91fb-74d766aef6a9 | 2026-01-12 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e3e9b582-fd15-4fe0-a210-398d9149696e | 2026-01-12 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Nifedipine | NIFEDIPINE | PD-Rx Pharmaceuticals, Inc. | 7160331a-8735-4bc0-8cb9-a8014512a669 | 2026-01-12 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Metoprolol Tartrate | METOPROLOL TARTRATE | PD-Rx Pharmaceuticals, Inc. | d3628f24-8076-4980-a358-8445ef8260f4 | 2026-01-12 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Acetaminophen | ACETAMINOPHEN | PD-Rx Pharmaceuticals, Inc. | 64696f65-415e-4ce1-a5b3-70662fbcb002 | 2026-01-12 | Warnings | PD-Rx Pharmaceuticals, Inc. |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 1ede17e6-19e9-455c-ad16-8029a590735c | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3c215e6c-d85a-4102-a1c2-f00fa3169a55 | 2026-01-08 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| DICYCLOMINE HYDROCHLORIDE | DICYCLOMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | dd3a8428-f71f-4f39-91c9-328d2a30eeba | 2026-01-08 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Metoprolol Tartrate | METOPROLOL TARTRATE | PD-Rx Pharmaceuticals, Inc. | 19678edf-934a-45f3-b5da-94d10e9b3248 | 2026-01-07 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e9450e82-329f-4fd8-a0b3-3e8e22715965 | 2026-01-07 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 8808879d-8c7e-45d1-8a49-c05d2cf845d3 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 00f67e1a-6999-4295-9c9f-fcb1ce9711b8 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | ec23c75d-68d5-46d0-be56-b96ddba19ed6 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 58c4261e-e98f-4280-9562-2800956dff14 | 2026-01-07 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 1b3c7d74-f80b-4fb1-8dca-66880af5d3fc | 2026-01-07 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | e01efe66-2f31-4261-92ca-0b41f27104da | 2026-01-07 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | PD-Rx Pharmaceuticals, Inc. | 87d78229-f022-4b42-a03c-4e6a985c714f | 2026-01-07 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Tizanidine | TIZANIDINE | PD-Rx Pharmaceuticals, Inc. | ac897a5a-677b-4a6e-abb1-b810470200fc | 2026-01-07 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.